Table 3 Complications and adverse outcomes between cases and controls.

From: The clinical characteristics and risk factors analysis within one week before the onset of necrotizing enterocolitis

Complications

NEC (n = 54)

Non-NEC (n = 180)

P

EOS (n/N, %)

0 (0.0)

0 (0.0)

NA

PDA (n/N, %)

27 (50.0)

54 (30.0)

0.011

RDS (n/N, %)

36 (66.7)

109 (60.6)

0.633

Moderate to severe BPD (n/N, %)

8 (14.8)

13 (7.2)

0.150

LOS before NEC (n/N, %)

9 (16.7)

17 (9.4)

0.217

LOS (n/N, %)

23 (42.6)

28 (15.6)

< 0.001

sIVH (n/N, %)

3 (5.6)

8 (4.4)

1.000

PVL (n/N, %)

1 (1.9)

7 (3.9)

0.768

sROP (n/N, %)

4 (7.4)

18 (10.0)

0.759

Death (n/N, %)

7 (13.0)

1 (0.6)

< 0.001

  1. NEC necrotizing enterocolitis, PDA patent ductus arteriosus, RDS respiratory distress syndrome, BPD bronchopulmonary dysplasia, EOS early-onset sepsis, LOS late-onset sepsis, sIVH severe intraventricular hemorrhage, PVL periventricular leukomalacia, sROP severe retinopathy of prematurity.
Back to article page